Gufic Biosciences Limited

Healthcare›Healthcare›Pharmaceuticals & Biotechnology›Pharmaceuticals

Ask AI

Key metrics

Price as of 2026-07-17

Stock price
₹381.90
Market cap
3,830 Cr
Stock P/E
60.2
P/B
5.76
Dividend yield
0.0%

Sign in for full ratios and TTM. Learn about these metrics →

Share price

NSE closing price from historical market data.

Loading price history…

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Sales410 Cr612 Cr807 Cr203 Cr407 Cr208 Cr205 Cr224 Cr237 Cr231 Cr252 Cr
Operating expenses (approx.)334 Cr499 Cr659 Cr166 Cr331 Cr172 Cr178 Cr189 Cr197 Cr198 Cr206 Cr
EBITDA76 Cr113 Cr148 Cr37 Cr76 Cr36 Cr27 Cr34 Cr40 Cr34 Cr46 Cr
OPM %18.6%18.5%18.4%18.3%18.6%17.2%13.1%15.3%16.9%14.6%18.3%
Other income0.87 Cr1 Cr2 Cr1 Cr1 Cr2 Cr0.39 Cr0.93 Cr2 Cr0.79 Cr-1 Cr
Interest9 Cr12 Cr15 Cr5 Cr10 Cr5 Cr8 Cr9 Cr10 Cr8 Cr9 Cr
Depreciation9 Cr13 Cr17 Cr4 Cr9 Cr5 Cr8 Cr8 Cr8 Cr8 Cr8 Cr
Profit before tax59 Cr89 Cr116 Cr28 Cr57 Cr26 Cr11 Cr17 Cr23 Cr18 Cr29 Cr
Tax %25.7%25.4%25.5%25.8%25.7%26.5%26.7%24.3%25.6%29.9%24.4%
Net profit44 Cr66 Cr86 Cr21 Cr43 Cr19 Cr8 Cr13 Cr17 Cr12 Cr22 Cr
EPS (₹)₹4.52₹6.75₹8.74₹2.08₹4.25₹1.93₹0.77₹1.30₹1.68₹1.24₹2.18

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2024Mar 2025Mar 2026TTM
Sales807 Cr820 Cr944 CrSign in for TTM
Operating expenses (approx.)661 Cr681 Cr790 CrSign in for TTM
EBITDA146 Cr138 Cr154 CrSign in for TTM
OPM %18.1%16.9%16.3%Sign in for TTM
Other income2 Cr4 Cr3 CrSign in for TTM
Interest15 Cr23 Cr37 CrSign in for TTM
Depreciation17 Cr21 Cr31 CrSign in for TTM
Profit before tax116 Cr94 Cr87 CrSign in for TTM
Tax %25.5%26.0%25.8%Sign in for TTM
Net profit86 Cr70 Cr64 CrSign in for TTM
EPS (₹)₹8.74₹6.95₹6.40Sign in for TTM
Dividend payout %1.1%1.4%1.6%Sign in for TTM
Sign in for TTM

Trailing twelve months totals and margin rows

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2024Mar 2025Mar 2026
Equity capital10 Cr10 Cr10 Cr
Reserves523 Cr591 Cr655 Cr
Borrowings317 Cr180 Cr280 Cr
Other liabilities243 Cr388 Cr397 Cr
Total liabilities1,093 Cr1,169 Cr1,342 Cr
Fixed assets (net)153 Cr500 Cr485 Cr
CWIP307 Cr22 Cr22 Cr
Investments2 Cr2 Cr2 Cr
Other assets601 Cr625 Cr803 Cr
Total assets1,093 Cr1,169 Cr1,342 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2024Mar 2025Mar 2026
Cash from operating activity-7 Cr123 Cr45 Cr
Cash from investing-102 Cr-71 Cr-31 Cr
Cash from financing82 Cr-37 Cr32 Cr
Net cash flow-27 Cr15 Cr46 Cr
Free cash flow (OCF − Capex)-120 Cr47 Cr14 Cr

Ratios

Ratios as reported or derived per annual period.

MetricMar 2024Mar 2025Mar 2026
ROCE %15.2%15.0%13.0%
ROE %16.2%0.0%0.0%
Debtor days149——
Inventory days214229278
Days payable178——
Cash conversion cycle186229278
Debt / equity0.600.300.42
Current ratio1.611.611.55
Net debt / EBITDA2.171.191.42

Compare with peers

Loading peers…